Cas:669068-74-0 tert-butyl 4-amino-4-(3-bromophenyl)piperidine-1-carboxylate manufacturer & supplier

Chemical Name:tert-butyl 4-amino-4-(3-bromophenyl)piperidine-1-carboxylate

CAS.NO:669068-74-0

Synonyms:tert-butyl 4-amino-4-(3-bromophenyl)piperidine-1-carboxylate

Molecular Formula:C₁₆H₂₃BrN₂O₂

Molecular Weight:355.27000

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:55.56000

Exact Mass:354.09400

LogP:4.27220

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like tert-butyl 4-amino-4-(3-bromophenyl)piperidine-1-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,tert-butyl 4-amino-4-(3-bromophenyl)piperidine-1-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,tert-butyl 4-amino-4-(3-bromophenyl)piperidine-1-carboxylate Use and application,tert-butyl 4-amino-4-(3-bromophenyl)piperidine-1-carboxylate technical grade,usp/ep/jp grade.

Related News: The CRL for the Cabenuva injection, containing two active ingredients cabotegravir and Janssen��s rilpivirine, follows U.S. market approval in April for its once-a-day pill Dovato, also a two-drug combination. tert-butyl 4-amino-4-(3-bromophenyl)piperidine-1-carboxylate manufacturer Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology. tert-butyl 4-amino-4-(3-bromophenyl)piperidine-1-carboxylate supplier “Whenever a company hires outside counsel to conduct an inquiry, it’s taken extremely seriously by the Justice Department,” said Paul Pelletier, a former long-time federal prosecutor who used to oversee criminal investigations of corporations. tert-butyl 4-amino-4-(3-bromophenyl)piperidine-1-carboxylate vendor The CRL for the Cabenuva injection, containing two active ingredients cabotegravir and Janssen��s rilpivirine, follows U.S. market approval in April for its once-a-day pill Dovato, also a two-drug combination. tert-butyl 4-amino-4-(3-bromophenyl)piperidine-1-carboxylate factory The third-to-market BTK inhibitor is also looking to report top-line results from a front-line trial later this year. Imbruvica could feel more pressure if that study also turns out successful.